× Important note: Due to the end of funding, these reviews are no longer in living mode. We try to update them on a monthly basis.

meta|Evidence - COVID-19

Living meta-analysis and evidence synthesis of therapies for COVID19  

Member of the meta|Evidence galaxy

tutorial video
En     Fr

Our approach

RSS

       
button bars forest bayes pooled summary circles
Treament Trials   auto
deathsclinical improvementdeath or ventilation
1 certainty unassessable-28% certainty unassessable+8%-
11 / 22 -8% certainty unassessable+4%-8%
10 -16%statistically conclusive+30% certainty unassessable-3%
38 / 51 -2%+9%-2%
4 / 7 statistically conclusive-29%statistically conclusive+24%-16%
1 / 2 --
1 / 2 certainty unassessable-47%- certainty unassessablestatistically conclusive-34%
2 statistically conclusive-23%--19%
12 / 16 -13%+39%-16%
22 / 38 statistically conclusivesafety concern-14%statistically conclusive+26%statistically conclusive-16%
4 / 7 -10% certainty unassessable+3% certainty unassessable+12%
4 / 5 +6% certainty unassessable-16% certainty unassessable-17%
1 certainty unassessable+9%--

Statistically conclusive: statistically significant with a strict control of overall risk of type 1 error (statistically demonstrated), does not take into account the risk of bias; suggested: nominally statistically significant but without a strict control of overall risk of type 1 error; inconclusive: not nominally statistically significant

149
treatments 		  718
studies with results 		  1743
studies screend 		  1629
references

This project is supported by a grant of the French Ministry of Health (Hospital Clinical Research Program, PHRC-N), Université de Lyon (UdL/Idex), and self-funded by Hospices Civils de Lyon, CNRS UMR5558 LBBE University Lyon-1.

     

- About - Our approach - Credits - RSS Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons